Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 4, 2013Archives of Pediatrics and Adolescent Medicine

The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAaron S. KellyPreventive CardiologyKRKyle RudserUniversity of MinnesotaBNBrandon M. NathanUniversity of Minnesota

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kelly et al. (2013) studied this question.

synapsesocial.com/papers/6a72b59535aa2c282ce36475https://doi.org/10.1001/jamapediatrics.2013.1045
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Change from baseline and analysis of covariance revisited2006 · 391 citations
  2. 2Predictors of Changes in Glucose Tolerance Status in Obese Youth2005 · 386 citations
  3. 3Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.1998 · 1,402 citations
  4. 4Circulating Oxidized LDL and Inflammation in Extreme Pediatric Obesity2011 · 99 citations
  5. 5Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes2011 · 157 citations